» Articles » PMID: 3145115

Effect of Declining Renal Function on Bone Density in Aging Women

Overview
Specialty Pathology
Date 1988 Jul 1
PMID 3145115
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

The factors that are responsible for trabecular bone loss in aging women are not completely understood. To evaluate declining renal function as a possible factor, we studied 19 Caucasian women (average age 67) who were from 6 to 41 years postmenopausal. Trabecular bone density was quantitated by computerized tomography of the spine. Serum calcium, phosphorus, and creatinine were normal in all subjects. Creatinine clearance averaged 74 ml/min (range 38-122), decreased with age (r = -0.60, P = 0.003), and was inversely related to serum creatinine (r = -0.51, P = 0.01). Bivariate regression demonstrated that bone density decreased with age (r = -0.59, P = 0.004); controlling for the effect of creatinine clearance weakened this correlation to r = -0.45 (P = 0.03); controlling additionally for 1,25-dihydroxyvitamin D [1,25(OH)2D] and parathyroid hormone (PTH) reduced the correlation coefficient to r = -0.34 (P = 0.11). Bone density also decreased in direct proportion to the decrement in creatinine clearance (r = 0.44, P = 0.03); controlling for the effects of 1,25(OH)2D and PTH reduced this correlation coefficient to r = 0.34 (P = 0.11). These results suggest that occult renal insufficiency may contribute to bone loss in aging women, and that this effect may be mediated in part by 1,25(OH)2D and PTH. In this age group renal function should be assessed by measuring creatinine clearance rather than the serum creatinine concentration since renal insufficiency can be masked by apparently normal circulating creatinine levels.

Citing Articles

The multi-faceted nature of age-associated osteoporosis.

Smit A, Meijer O, Winter E Bone Rep. 2024; 20:101750.

PMID: 38566930 PMC: 10985042. DOI: 10.1016/j.bonr.2024.101750.


Association between renal function and bone mineral density in patients with type 2 diabetes mellitus.

Ye Y, Yi X, Zhang Y, Xu G, Yu M, Qu X Heliyon. 2023; 9(5):e15967.

PMID: 37215877 PMC: 10195895. DOI: 10.1016/j.heliyon.2023.e15967.


Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.

Thongprayoon C, Acharya P, Acharya C, Chenbhanich J, Bathini T, Boonpheng B Osteoporos Int. 2018; 29(8):1737-1745.

PMID: 29713798 DOI: 10.1007/s00198-018-4533-6.


Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study.

Malmgren L, McGuigan F, Christensson A, Akesson K Osteoporos Int. 2017; 28(12):3463-3473.

PMID: 29038837 PMC: 5684332. DOI: 10.1007/s00198-017-4221-y.


A decline in renal function is associated with loss of bone mass in Korean postmenopausal women with mild renal dysfunction.

Kim H, Park I, Choi J, Hwang S, Kim H, Lim J J Korean Med Sci. 2011; 26(3):392-8.

PMID: 21394308 PMC: 3051087. DOI: 10.3346/jkms.2011.26.3.392.


References
1.
Rosenthal D, Ganott M, Wyshak G, Slovik D, Doppelt S, Neer R . Quantitative computed tomography for spinal density measurement. Factors affecting precision. Invest Radiol. 1985; 20(3):306-10. DOI: 10.1097/00004424-198505000-00014. View

2.
Cann C, Genant H, KOLB F, Ettinger B . Quantitative computed tomography for prediction of vertebral fracture risk. Bone. 1985; 6(1):1-7. DOI: 10.1016/8756-3282(85)90399-0. View

3.
Francis R, Peacock M, Taylor G, Storer J, Nordin B . Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D metabolites on the bowel. Clin Sci (Lond). 1984; 66(1):103-7. DOI: 10.1042/cs0660103. View

4.
JOHNSTON Jr C, Hui S, Witt R, Appledorn R, Baker R, Longcope C . Early menopausal changes in bone mass and sex steroids. J Clin Endocrinol Metab. 1985; 61(5):905-11. DOI: 10.1210/jcem-61-5-905. View

5.
Manolagas S, Culler F, Howard J, Brickman A, Deftos L . The cytoreceptor assay for 1,25-dihydroxyvitamin D and its application to clinical studies. J Clin Endocrinol Metab. 1983; 56(4):751-60. DOI: 10.1210/jcem-56-4-751. View